Table 1. Clinical characteristics of the BECTS patients and healthy controls.
| Clinical characteristic | BECTS | Controls | p |
|---|---|---|---|
| Number of subjects | 19 | 23 | - |
| Sex (male:female) | 10:9 | 9:14 | 0.382 |
| Age at fMRI study (years) | 13.42±2.29 | 12.17±2.74 | 0.122 |
| Age at onset (years) | 7.37±2.71 | - | - |
| Duration of seizure (months) | 30.89±40.83 | - | - |
| AED at fMRI study | |||
| Duration (months) | 57.42±19.26 | - | - |
| Type, n (%) | |||
| None | 3 (15.8) | ||
| Carbamazepine | 2 (10.5) | ||
| Oxcarbazepine | 5 (26.3) | ||
| Valproic acid | 5 (26.3) | ||
| Lamotrigine | 2 (10.5) | ||
| Dual treatment | 2 (10.5) | ||
| EEG epileptiform discharges | |||
| Location, n (%) | |||
| Left CT or CTP | 8 (42.1) | ||
| Right CT or CTP | 4 (21.1) | ||
| Both CT or CTP | 7 (36.8) | ||
| Frequency, n (%) | |||
| None | 9 (47.4) | ||
| Rare (≤1 per 10 min) | 2 (10.5) | ||
| Occasional (≤1 per min) | 0 | ||
| Frequent (>1 per min) | 3 (15.8) | ||
| Abundant (≥1 per 10 sec) | 5 (26.3) |
Data are n (%) or mean±standard deviation values.
AED: antiepileptic drug, BECTS: benign childhood epilepsy with centrotemporal spikes, CT: centrotemporal, CTP: centrotemporoparietal, EEG: electroencephalography, fMRI: functional magnetic resonance imaging.